These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Editorial comment: boosted PIs and metabolism--it's not just the ritonavir. Moyle GJ AIDS Read; 2005 Oct; 15(10):531. PubMed ID: 16265769 [No Abstract] [Full Text] [Related]
23. Influence of indinavir and ritonavir on warfarin anticoagulant activity. Gatti G; Alessandrini A; Camera M; Di Biagio A; Bassetti M; Rizzo F AIDS; 1998 May; 12(7):825-6. PubMed ID: 9619821 [No Abstract] [Full Text] [Related]
24. Cholesterol levels in HIV-HCV infected patients treated with lopinavir/r: results from the SCOLTA project. De Socio GV; Bonfanti P; Ricci E; Orofino G; Madeddu G; Penco G; Gianelli E; Martinelli C; Carradori S; Quirino T; Rizzardini G; Biomed Pharmacother; 2008 Jan; 62(1):16-20. PubMed ID: 17851026 [TBL] [Abstract][Full Text] [Related]
31. Antiretroviral activity and safety of lopinavir/ritonavir in protease inhibitor-experienced HIV-infected children with severe-moderate immunodeficiency. Resino S; Bellón JM; Muñoz-Fernández MA; J Antimicrob Chemother; 2006 Mar; 57(3):579-82. PubMed ID: 16446377 [No Abstract] [Full Text] [Related]
32. [Are all boosted protease inhibitors the same? Previously treated patients profit too from lopinavir/r]. MMW Fortschr Med; 2003 Dec; 145(50):61. PubMed ID: 14963981 [No Abstract] [Full Text] [Related]
33. Two newcomers may challenge ritonavir's position as the only booster for HIV therapy. Proj Inf Perspect; 2009 Mar; (48):10-1. PubMed ID: 19492462 [No Abstract] [Full Text] [Related]
34. The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients. Chang ES; Tetreault DD; Liu YT; Beall GN J Am Diet Assoc; 2001 Jun; 101(6):687-9. PubMed ID: 11424549 [No Abstract] [Full Text] [Related]
35. Ritonavir (Norvir) and methadone. Treat Rev; 1998; (No 28):15. PubMed ID: 11365421 [TBL] [Abstract][Full Text] [Related]